Kestra Medical Technologies, Ltd. Deferred Income Tax Expense (Benefit)
Kestra Medical Technologies, Ltd. (KMTS) reported Deferred Income Tax Expense (Benefit) of $166.00 thousand for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-14
- Kestra Medical Technologies, Ltd. deferred income tax expense (benefit) for fiscal 2026 was $166.00K, a 159.38% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. deferred income tax expense (benefit) for fiscal 2025 was $64.00K, a 433.33% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. deferred income tax expense (benefit) for fiscal 2024 was $12.00K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2026-04-30 | $166.00K 10-K · filed 2026-07-14 |
| 2025-04-30 | $64.00K 10-K · filed 2026-07-14 |
| 2024-04-30 | $12.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |